Information about Aristada and Aristada Initio Dosage: Forms, Strengths, and Additional Details
In the field of mental health, Aristada and Aristada Initio are two significant long-acting injectable treatments for schizophrenia. Both medications contain the active ingredient aripiprazole lauroxil, a formulation designed for extended release.
Aristada Initio is a rapid initiation formulation, given as a single injection to quickly achieve therapeutic levels of aripiprazole. It is administered concurrently with a one-month dose of oral aripiprazole supplementation. Following the initiation phase, Aristada maintenance doses are given intramuscularly every 4, 6, or 8 weeks, depending on the prescribed dose strength and patient needs.
The dosing intervals and strengths typically are:
- 441 mg injected every 4 weeks
- 662 mg injected every 6 weeks
- 882 mg injected every 6 weeks
- 1064 mg injected every 8 weeks
The exact dosing schedule and interval choice are individualized based on response and tolerability. It's worth noting that Aristada Initio doses can be injected into either a shoulder or buttock, while all Aristada doses can be injected into a buttock muscle.
Aristada is designed to maintain steady aripiprazole plasma levels with reduced injection frequency compared to daily oral dosing. Oral aripiprazole is used only with the initial Aristada Initio dose and is discontinued once Aristada injections are established.
For comparison, oral aripiprazole tablets for schizophrenia in adults are typically 10 to 15 mg once daily, with a maximum dose of 30 mg daily.
Before starting Aristada treatment, the doctor checks whether the patient has ever taken Abilify (aripiprazole). Dosage adjustments may be necessary based on other drugs the patient is taking, other medical conditions, and the severity of the schizophrenia.
It's important to note that Aristada and Aristada Initio aren't currently available in generic forms. Moreover, Aristada is meant for long-term treatment, while Aristada Initio is not usually prescribed long term. If a missed dose of either medication occurs, the patient should call their doctor to reschedule.
Both Aristada and Aristada Initio belong to the drug class known as atypical antipsychotics. While there is currently no generic form of aripiprazole lauroxil, these extended-release liquid suspensions prescribed for schizophrenia in adults continue to make a significant impact in the management of this condition.
- The long-acting injectable treatment Aristada Initio, used for Schizophrenia, is a rapid initiation formulation that achieves therapeutic levels quickly, administered as a single injection concurrently with a one-month dose of oral aripiprazole supplementation.
- In the health-and-wellness field, Aristada is another important long-acting injectable treatment for Schizophrenia, designed to maintain steady aripiprazole plasma levels with reduced injection frequency compared to daily oral dosing, often prescribed every 4, 6, or 8 weeks.
- Both Aristada and Aristada Initio, belonging to the drug class of atypical antipsychotics, are crucial therapies-and-treatments in the management of Schizophrenia, even though a generic form of aripiprazole lauroxil is not currently available.
- It's essential to consider mental health when discussing the use of drugs like Aristada Initio and Aristada, particularly in the context of Schizophrenia treatment, as dosage adjustments may be necessary due to other drugs being taken, medical conditions, and the severity of the Schizophrenia.
